PlayOn11 - Where Fans Become Winners
Odyssey CEO sees $304M IPO creating ‘little large pharma’

Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $3...

BUSINESS NEWS May 08, 2026

Odyssey CEO sees $304M IPO creating ‘little large pharma’

Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $304 million IPO this morning.

1 views 0 likes 0 comments
Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $304 million IPO this morning.

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
Ads with us
Advertisement

Top Categories

Advertisement
Ads with us
Advertisement
Ads with us
Advertisement
Ads with us
Advertisement
Ads with us